CS MEDICA A/S
CS MEDICA A/S
NuWays RecommendationRecommendation
Buy
Price Target
€2.30
Upside
379.17%
Chart
- 1M
- 3M
- 6M
- YTD
- 1Y
- 3Y
€0.48
€0.01 (2.99%)
Realtime-Data from Invalid Date
CS MEDICA is a Danish Med-Tech company founded in 2011. It researches and utilizes different compounds found in the cannabis plant and thereby has created 10+ products that effectively and safely treat autoimmune and stress-related disorders from arthritis and psoriasis to hair loss as well as wound and pain care. Its vision is to innovate the current landscape of alternative pharmacological and medical treatments by making use of the ingredient CBD in its products in the form of gels, creams, and sprays, and showcasing equal to superior efficacy and fewer side effects when compared to conventional products.
Ticker
8G8 GR
Market Cap
€8.21 M
Enterprise Value
€9.44 M
26 week avg vol.
1500
Primar Exchange
Xetra
IPO
2021
Sector
Health Care & Pharma
Headquarters
Copenhagen, DK
Employees
16
Incorporated
2011
CEO
Lone Henriksen
Website
Lone Henriksen
33.87%
Gitte Henriksen
32.88%
Finn-Ove Henriksen and Nina Henriksen
3.34%
Diaz Capital Invest AB
3.16%
14.11.2024
Publication of annual report
28.11.2024
Publication of annual report
17.12.2024
Annual General Meeting
KPIs in DKK
KPI | 2023 | 2024e | 2025e |
---|---|---|---|
Sales | 1.07 M | 16.15 M | 33.83 M |
EBITDA | (15.82 M) | (11.95 M) | (3.38 M) |
EBIT | (17.90 M) | (14.05 M) | (5.75 M) |
EPS | (1.18) | (1.08) | (0.78) |
FCF | (10.52 M) | (19.71 M) | (9.64 M) |
Valuation
KPI | 2023 | 2024e | 2025e |
---|---|---|---|
EV / Sales | 65.96x | 5.58x | 2.95x |
EV / EBITDA | (4.45x) | (7.54x) | (29.49x) |
EV / EBIT | (3.93x) | (6.41x) | (17.35x) |
Price / Earnings | (3.04x) | (3.32x) | (4.61x) |
EV / FCF | (6.69x) | (4.57x) | (10.35x) |
Downloads
Latest Research
Initiation